Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07337642 · ClinicalTrials.gov registry record · NA

Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty

A NA study of Primary Total Hip Arthroplasty, sponsored by Medstar Health Research Institute.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07337642: Recruiting NA study of Primary Total Hip Arthroplasty, sponsored by Medstar Health Research Institute.

NCT07337642 is a NA study of Primary Total Hip Arthroplasty that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07337642, a NA study of Primary Total Hip Arthroplasty, is actively recruiting participants, sponsored by Medstar Health Research Institute.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to: SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared versus collarless femoral stem of the same design. SA2: Evaluate serial radiographs to quantify differences in subsidence between collared and collarless implant groups. SA3: Report and compare incidence rates of intraoperative and postoperative periprosthetic fractures and aseptic loosening following primary total hip arthroplasty with use of either a collared or collarless stem. Hypothesis: The addition of a collar to the same designed triple-taper primary hip stem will lead to a reduction in subsidence and incidence of perioperative and periprosthetic femur fractures.

Primary Outcome

Measurement of femoral stem subsidence at 6 weeks, 6 months, and 1-year post-operation used radiographic evidence.

Interventions

  • OTHER Collarless Femoral Stem
  • OTHER Collared Femoral Stem

Study Locations (1)

District of Columbia

  • MedStar Georgetown University Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-12-03
Est. Completion 2027-12-31
Phase NA
Medstar Health Research Institute

115 total trials

What NCT07337642 shows while recruiting

NCT07337642 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Primary Total Hip Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Collarless Femoral Stem is the first listed.

NCT07337642 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT07337642 about?

NCT07337642 is a clinical study titled "Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty". This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to: SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared ver...

What is the current status of trial NCT07337642?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-03. Estimated completion is 2027-12-31.

What conditions does trial NCT07337642 study?

This clinical trial studies the following conditions: Primary Total Hip Arthroplasty.

What interventions are being tested in trial NCT07337642?

The interventions under investigation include: Collarless Femoral Stem (OTHER), Collared Femoral Stem (OTHER).

Who is sponsoring clinical trial NCT07337642?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07337642 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Total Hip Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07337642's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07337642, the US trial registry maintained by the National Library of Medicine. NCT07337642 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.